DNA sequence variation may modulate onset of ER positive breast cancer and its recurr

[News]

Investigators at The Cancer Institute of New Jersey have presented new research at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium. Their work highlights how a variation in a person's DNA sequence is associated with an earlier age of onset for breast cancer that is stimulated by the hormone estrogen (estrogen receptor positive).

More... (http://www.news-medical.net/news/20101213/DNA-sequence-variation-may-modulate-onset-of-ER-positive-breast-cancer-and-its-recurrence.aspx)